Morgan Stanley’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.2M | Buy |
585,355
+396,611
| +210% | +$11.6M | ﹤0.01% | 2961 |
|
|
2025
Q1 | $4.85M | Buy |
188,744
+96,460
| +105% | +$2.48M | ﹤0.01% | 3953 |
|
|
2024
Q4 | $2.66M | Buy |
92,284
+41,806
| +83% | +$1.21M | ﹤0.01% | 4497 |
|
|
2024
Q3 | $1.2M | Sell |
50,478
-15,697
| -24% | -$373K | ﹤0.01% | 4942 |
|
|
2024
Q2 | $1.14M | Buy |
66,175
+38,964
| +143% | +$674K | ﹤0.01% | 4875 |
|
|
2024
Q1 | $608K | Sell |
27,211
-31,297
| -53% | -$699K | ﹤0.01% | 5221 |
|
|
2023
Q4 | $1.07M | Buy |
58,508
+37,656
| +181% | +$691K | ﹤0.01% | 5260 |
|
|
2023
Q3 | $362K | Buy |
20,852
+10,578
| +103% | +$184K | ﹤0.01% | 5310 |
|
|
2023
Q2 | $187K | Sell |
10,274
-18,915
| -65% | -$344K | ﹤0.01% | 5677 |
|
|
2023
Q1 | $501K | Buy |
29,189
+24,146
| +479% | +$414K | ﹤0.01% | 5254 |
|
|
2022
Q4 | $117K | Buy |
5,043
+568
| +13% | +$13.2K | ﹤0.01% | 5909 |
|
|
2022
Q3 | $100K | Sell |
4,475
-98,446
| -96% | -$2.2M | ﹤0.01% | 6080 |
|
|
2022
Q2 | $1.98M | Buy |
102,921
+22,545
| +28% | +$434K | ﹤0.01% | 4551 |
|
|
2022
Q1 | $2.87M | Sell |
80,376
-19,393
| -19% | -$692K | ﹤0.01% | 4240 |
|
|
2021
Q4 | $8.68M | Buy |
99,769
+40,660
| +69% | +$3.54M | ﹤0.01% | 3099 |
|
|
2021
Q3 | $6.78M | Buy |
59,109
+21,466
| +57% | +$2.46M | ﹤0.01% | 3359 |
|
|
2021
Q2 | $8.1M | Buy |
+37,643
| New | +$8.1M | ﹤0.01% | 3242 |
|